Wilson Sonsini Goodrich & Rosati advised Gauss Surgical on the deal.
Diagnostic maker Cellex announced plans to develop a rapid coronavirus infection test that people can fully perform at home, from sample collection to result—with 15-minute readings double-checked by a personal smartphone app. The company is partnering with Gauss Surgical, a developer of machine vision-based software programs, to help digitize the results of its upcoming COVID-19 antigen test.
Cellex said it is currently working to validate its diagnostic, which has previously shown a false negative rate of about 10 percent while returning no false positive results, through clinical trials. Meanwhile, the smartphone app from Gauss aims to provide step-by-step video instructions on how to self-collect a nasal swab sample and perform the test. After 15 minutes, the app prompts the user to scan the result using the smartphone’s camera, which reads the image and confirms whether it is positive or negative.
Cellex and Gauss said they aim to have the antigen test and companion app authorized by the FDA this fall.
The Wilson Sonsini team that advised Gauss in the collaboration includes Christopher Paniewski (Picture) and Nayha Lang.
Law Firms: Wilson Sonsini Goodrich & Rosati;
Clients: Gauss Surgical;